ZME Science on MSN
FDA Refuses To Review Moderna mRNA Flu Vaccine and the US Could Miss Out on Next Generation Fu Shots
In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine.
The flu vaccine is its first using mRNA technology for influenza.
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
Moderna Inc.’s shares fell after US regulators refused to review its novel mRNA flu vaccine, creating regulatory chaos for ...
The flu vaccine may not be very effective this winter, according to U.S. health officials who worry this may lead to more serious illnesses and deaths. As flu season begins to ramp up, officials say ...
An Ascension St. Vincent's pediatrician weighs in on the new flu variant causing a spike in cases, with advice on symptoms and where to go for care.
Add Yahoo as a preferred source to see more of our stories on Google. Flu is surging across most of the U.S. But, amid an early, harsh season, there is a glimmer of promising news: The flu shot may be ...
As families navigate the current flu season, many are feeling the impact more intensely than in previous years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results